Published in Br J Pharmacol on September 24, 2007
Lipid G protein-coupled receptor ligand identification using beta-arrestin PathHunter assay. J Biol Chem (2009) 1.91
Cannabinoids as novel anti-inflammatory drugs. Future Med Chem (2009) 1.58
Immunoregulation of a CB2 receptor agonist in a murine model of neuroAIDS. J Neuroimmune Pharmacol (2010) 1.10
The endocannabinoid system and the regulation of neural development: potential implications in psychiatric disorders. Eur Arch Psychiatry Clin Neurosci (2009) 1.04
Role of cannabinoids and endocannabinoids in cerebral ischemia. Curr Pharm Des (2008) 0.92
Regulatory role of cannabinoid receptor 1 in stress-induced excitotoxicity and neuroinflammation. Neuropsychopharmacology (2010) 0.92
Inhibition of FAAH and activation of PPAR: new approaches to the treatment of cognitive dysfunction and drug addiction. Pharmacol Ther (2013) 0.92
Cannabinoid receptor CB2 protects against balloon-induced neointima formation. Am J Physiol Heart Circ Physiol (2012) 0.83
Cannabinoid modulation of neuroinflammatory disorders. Curr Neuropharmacol (2012) 0.80
Pleiotropic effects of the CB2 cannabinoid receptor activation on human monocyte migration: implications for atherosclerosis and inflammatory diseases. Am J Physiol Heart Circ Physiol (2008) 0.80
A Sativex(®) -like combination of phytocannabinoids as a disease-modifying therapy in a viral model of multiple sclerosis. Br J Pharmacol (2015) 0.77
Strategies for protecting oligodendrocytes and enhancing remyelination in multiple sclerosis. Discov Med (2013) 0.77
Design and evaluation of a novel fluorescent CB2 ligand as probe for receptor visualization in immune cells. Bioorg Med Chem Lett (2011) 0.76
Vascular Dysfunction in a Transgenic Model of Alzheimer's Disease: Effects of CB1R and CB2R Cannabinoid Agonists. Front Neurosci (2016) 0.75
Brain innate immunity in the regulation of neuroinflammation: therapeutic strategies by modulating CD200-CD200R interaction involve the cannabinoid system. Curr Pharm Des (2014) 0.75
The nervous and the immune systems: conspicuous physiological analogies. J Comp Physiol A Neuroethol Sens Neural Behav Physiol (2014) 0.75
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med (2005) 28.73
Subventricular zone astrocytes are neural stem cells in the adult mammalian brain. Cell (1999) 15.87
Molecular characterization of a peripheral receptor for cannabinoids. Nature (1993) 13.45
Axonal transection in the lesions of multiple sclerosis. N Engl J Med (1998) 12.21
Functional neurogenesis in the adult hippocampus. Nature (2002) 11.17
The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev (2006) 6.80
For the long run: maintaining germinal niches in the adult brain. Neuron (2004) 6.01
Identification and functional characterization of brainstem cannabinoid CB2 receptors. Science (2005) 5.12
Origin of oligodendrocytes in the subventricular zone of the adult brain. J Neurosci (2006) 4.90
Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis. Nat Med (2005) 4.67
Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur J Biochem (1995) 4.53
Early determination and long-term persistence of adult-generated new neurons in the hippocampus of mice. Development (2003) 4.49
Axonal damage in acute multiple sclerosis lesions. Brain (1997) 3.88
Selective vulnerability of late oligodendrocyte progenitors to hypoxia-ischemia. J Neurosci (2002) 3.50
Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system. Cell (1996) 3.48
Interleukin-1beta enhances NMDA receptor-mediated intracellular calcium increase through activation of the Src family of kinases. J Neurosci (2003) 3.38
Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system. Neurology (1987) 3.11
Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. J Immunol (1992) 3.07
Neurogenesis in the adult brain: new strategies for central nervous system diseases. Annu Rev Pharmacol Toxicol (2004) 2.94
NG2-positive oligodendrocyte progenitor cells in adult human brain and multiple sclerosis lesions. J Neurosci (2000) 2.87
Cannabinoid CB2 receptors: immunohistochemical localization in rat brain. Brain Res (2006) 2.62
The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells. Neuron (2006) 2.55
Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J Immunol (1993) 2.53
Peroxynitrite generated by inducible nitric oxide synthase and NADPH oxidase mediates microglial toxicity to oligodendrocytes. Proc Natl Acad Sci U S A (2005) 2.30
Immunoglobulins promote remyelination in the central nervous system. Ann Neurol (1990) 2.27
Cytokines in inflammatory brain lesions: helpful and harmful. Trends Neurosci (1996) 2.20
Interferon-gamma-induced oligodendrocyte cell death: implications for the pathogenesis of multiple sclerosis. Mol Med (1995) 2.15
Epidemiologic evidence for multiple sclerosis as an infection. Clin Microbiol Rev (1993) 2.12
Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer's disease brains. J Neurosci (2003) 2.04
IL-6-deficient mice are resistant to the induction of experimental autoimmune encephalomyelitis provoked by myelin oligodendrocyte glycoprotein. Int Immunol (1998) 2.00
Axonal pathology in multiple sclerosis: relationship to neurologic disability. Curr Opin Neurol (1999) 1.91
The ALIAmide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar granule neurons. Proc Natl Acad Sci U S A (1996) 1.84
Multiple sclerosis: altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage. Ann Neurol (2001) 1.78
Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli. J Neurochem (2005) 1.78
Cannabinoids control spasticity and tremor in a multiple sclerosis model. Nature (2000) 1.77
Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB1 on neurons and CB2 on autoreactive T cells. Nat Med (2007) 1.69
Cannabinoid CB2 receptor: a new target for controlling neural cell survival? Trends Pharmacol Sci (2006) 1.66
Linkage of the MHC to familial multiple sclerosis suggests genetic heterogeneity. The Multiple Sclerosis Genetics Group. Hum Mol Genet (1998) 1.63
Cannabinoids and neuroinflammation. Br J Pharmacol (2004) 1.62
Cannabinoids inhibit neurodegeneration in models of multiple sclerosis. Brain (2003) 1.62
Cannabinoids promote oligodendrocyte progenitor survival: involvement of cannabinoid receptors and phosphatidylinositol-3 kinase/Akt signaling. J Neurosci (2002) 1.61
Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors. Brain Res Mol Brain Res (2004) 1.59
Cannabinoid CB(2) receptor activation decreases cerebral infarction in a mouse focal ischemia/reperfusion model. J Cereb Blood Flow Metab (2007) 1.59
Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation. J Neuroinflammation (2005) 1.57
Identification of post-mitotic oligodendrocytes incapable of remyelination within the demyelinated adult spinal cord. J Neuropathol Exp Neurol (1997) 1.53
The endocannabinoid system drives neural progenitor proliferation. FASEB J (2005) 1.51
Synthetic cannabinoid WIN55,212-2 inhibits generation of inflammatory mediators by IL-1beta-stimulated human astrocytes. Glia (2005) 1.49
Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid-type CB2 receptor. Br J Pharmacol (2003) 1.47
Therapeutic action of cannabinoids in a murine model of multiple sclerosis. J Neurosci (2003) 1.47
Differential expression of the CB2 cannabinoid receptor by rodent macrophages and macrophage-like cells in relation to cell activation. Int Immunopharmacol (2002) 1.44
Endocannabinoids control spasticity in a multiple sclerosis model. FASEB J (2000) 1.44
Cannabinoid CB2 receptors are expressed by perivascular microglial cells in the human brain: an immunohistochemical study. Synapse (2004) 1.42
Targeted CNS expression of interferon-gamma in transgenic mice leads to hypomyelination, reactive gliosis, and abnormal cerebellar development. Mol Cell Neurosci (1996) 1.42
Mechanisms of immune injury in multiple sclerosis. Brain Pathol (1996) 1.30
Cannabinoids inhibit LPS-inducible cytokine mRNA expression in rat microglial cells. Glia (2000) 1.30
Delta 9-Tetrahydrocannabinol regulates Th1/Th2 cytokine balance in activated human T cells. J Neuroimmunol (2002) 1.29
The endogenous cannabinoid system and brain development. Trends Neurosci (2000) 1.28
Non-psychoactive CB2 cannabinoid agonists stimulate neural progenitor proliferation. FASEB J (2006) 1.28
The cannabinoid system and cytokine network. Proc Soc Exp Biol Med (2000) 1.27
Cannabinoid receptor CB2 modulates the CXCL12/CXCR4-mediated chemotaxis of T lymphocytes. Mol Immunol (2006) 1.26
Immunoregulation of a viral model of multiple sclerosis using the synthetic cannabinoid R+WIN55,212. J Clin Invest (2003) 1.26
Primary demyelination in transgenic mice expressing interferon-gamma. Nat Med (1997) 1.26
Delta-9-THC in the treatment of spasticity associated with multiple sclerosis. Adv Alcohol Subst Abuse (1987) 1.26
Interleukin-1beta promotes oligodendrocyte death through glutamate excitotoxicity. Ann Neurol (2003) 1.24
Presence and regulation of the endocannabinoid system in human dendritic cells. Eur J Biochem (2002) 1.22
Cannabinoid CB1 and CB2 receptors and fatty acid amide hydrolase are specific markers of plaque cell subtypes in human multiple sclerosis. J Neurosci (2007) 1.21
CB2 cannabinoid receptor agonist, JWH-015, triggers apoptosis in immune cells: potential role for CB2-selective ligands as immunosuppressive agents. Clin Immunol (2006) 1.20
The relationship between viral RNA, myelin-specific mRNAs, and demyelination in central nervous system disease during Theiler's virus infection. Am J Pathol (1990) 1.20
Activation of cannabinoid CB2 receptor negatively regulates IL-12p40 production in murine macrophages: role of IL-10 and ERK1/2 kinase signaling. Br J Pharmacol (2005) 1.20
Roles of the mammalian subventricular zone in cell replacement after brain injury. Prog Neurobiol (2004) 1.19
Cellular signal transduction by anandamide and 2-arachidonoylglycerol. Chem Phys Lipids (2000) 1.17
The critical role of IL-12 and the IL-12R beta 2 subunit in the generation of pathogenic autoreactive Th1 cells. Springer Semin Immunopathol (1999) 1.16
Endogenous interleukin-1 receptor antagonist mediates anti-inflammatory and neuroprotective actions of cannabinoids in neurons and glia. J Neurosci (2003) 1.14
Modulation and functional involvement of CB2 peripheral cannabinoid receptors during B-cell differentiation. Blood (1998) 1.13
Interleukin-1 regulates proliferation and differentiation of oligodendrocyte progenitor cells. Mol Cell Neurosci (2002) 1.12
The role of oligodendrocytes and oligodendrocyte progenitors in CNS remyelination. Adv Exp Med Biol (1999) 1.11
Oligodendrocyte and axon pathology in clinically silent multiple sclerosis lesions. Mult Scler (1998) 1.11
Effect of reactive oxygen species on myelin membrane proteins. J Neurochem (1985) 1.10
Recombinant human IL-6 suppresses demyelination in a viral model of multiple sclerosis. J Immunol (1994) 1.10
Developing and mature oligodendrocytes respond differently to the immune cytokine interferon-gamma. J Neurosci Res (1998) 1.09
CB2 cannabinoid receptors promote mouse neural stem cell proliferation. Eur J Neurosci (2007) 1.08
Neurogenesis and brain injury: managing a renewable resource for repair. J Clin Invest (2003) 1.08
Delta 9-tetrahydrocannabinol: a novel treatment for experimental autoimmune encephalomyelitis. J Neuroimmunol (1989) 1.06
Role of CB1 and CB2 receptors in the inhibitory effects of cannabinoids on lipopolysaccharide-induced nitric oxide release in astrocyte cultures. J Neurosci Res (2002) 1.06
The virology of demyelinating diseases. Ann Neurol (1994) 1.05
LPS/IFN-gamma cytotoxicity in oligodendroglial cells: role of nitric oxide and protection by the anti-inflammatory cytokine IL-10. Eur J Neurosci (2001) 1.05
Th17 and Th1 responses directed against the immunizing epitope, as opposed to secondary epitopes, dominate the autoimmune repertoire during relapses of experimental autoimmune encephalomyelitis. J Neurosci Res (2007) 1.03
Genetic programs and responses of neural stem/progenitor cells during demyelination: potential insights into repair mechanisms in multiple sclerosis. Physiol Genomics (2003) 1.02
Differential expression of cannabinoid CB(2) receptor mRNA in mouse immune cell subpopulations and following B cell stimulation. Eur J Pharmacol (2001) 1.02
The endocannabinoid system and neurogenesis in health and disease. Neuroscientist (2007) 1.02
Effect of cyclosporin A, silica quartz dust, and protease inhibitors on virus-induced demyelination. J Neuroimmunol (1986) 1.01
Insulin-like growth factor I protects oligodendrocytes from tumor necrosis factor-alpha-induced injury. Endocrinology (1999) 1.01
Tetrahydrocannabinol for tremor in multiple sclerosis. Ann Neurol (1983) 1.00
Excitotoxicity in a chronic model of multiple sclerosis: Neuroprotective effects of cannabinoids through CB1 and CB2 receptor activation. Mol Cell Neurosci (2007) 0.98
Interferon-gamma synergises with tumour necrosis factor and lymphotoxin-alpha to enhance the mRNA and protein expression of adhesion molecules in mouse brain endothelial cells. Cytokine (2007) 0.96
Endocannabinoids: a new family of lipid mediators involved in the regulation of neural cell development. Curr Pharm Des (2006) 0.95
The endogenous cannabinoid anandamide potentiates interleukin-6 production by astrocytes infected with Theiler's murine encephalomyelitis virus by a receptor-mediated pathway. FEBS Lett (1998) 0.95
Prevention of neuron and oligodendrocyte degeneration by interleukin-6 (IL-6) and IL-6 receptor/IL-6 fusion protein in organotypic hippocampal slices. Mol Cell Neurosci (2004) 0.93
Value of annular M-mode displacement vs tissue Doppler velocities to assess cardiac function in intrauterine growth restriction. Ultrasound Obstet Gynecol (2013) 2.01
Experience-dependent facilitating effect of corticosterone on spatial memory formation in the water maze. Eur J Neurosci (1997) 1.90
Induction of COX-2 and PGE(2) biosynthesis by IL-1beta is mediated by PKC and mitogen-activated protein kinases in murine astrocytes. Br J Pharmacol (2000) 1.13
Ontogeny of sensorimotor gating and immune impairment induced by prenatal immune challenge in rats: implications for the etiopathology of schizophrenia. Mol Psychiatry (2008) 1.07
A cannabinoid agonist interferes with the progression of a chronic model of multiple sclerosis by downregulating adhesion molecules. Mol Cell Neurosci (2008) 1.07
LPS/IFN-gamma cytotoxicity in oligodendroglial cells: role of nitric oxide and protection by the anti-inflammatory cytokine IL-10. Eur J Neurosci (2001) 1.05
Involvement of 5-HT1A receptors in behavioural effects of the cannabinoid receptor agonist CP 55,940 in male rats. Behav Pharmacol (2004) 0.98
Sound stimulation and its effects on the pituitary-adrenocortical function and brain catecholamines in rats. Neuroendocrinology (1980) 0.97
The endogenous cannabinoid anandamide potentiates interleukin-6 production by astrocytes infected with Theiler's murine encephalomyelitis virus by a receptor-mediated pathway. FEBS Lett (1998) 0.95
Involvement of the kappa-opioid receptor in the anxiogenic-like effect of CP 55,940 in male rats. Pharmacol Biochem Behav (2003) 0.94
Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: a role for A2A receptors. Neurobiol Dis (2013) 0.94
Accuracy of four-dimensional spatiotemporal image correlation echocardiography in the prenatal diagnosis of congenital heart defects. Ultrasound Obstet Gynecol (2010) 0.92
Novelty-related rapid locomotor effects of corticosterone in rats. Eur J Neurosci (1996) 0.92
Pharmacological and functional characterization of muscarinic receptor subtypes in developing oligodendrocytes. J Neurochem (2001) 0.91
Re-evaluation of nestin as a marker of oligodendrocyte lineage cells. Microsc Res Tech (2001) 0.91
Adolescent exposure to nicotine modifies acute functional responses to cannabinoid agonists in rats. Behav Brain Res (2006) 0.91
Evidence of second-trimester changes in head biometry and brain perfusion in fetuses with congenital heart disease. Ultrasound Obstet Gynecol (2014) 0.90
An endocannabinoid tone limits excitotoxicity in vitro and in a model of multiple sclerosis. Neurobiol Dis (2009) 0.90
Nitric oxide synthesis inhibitors prevent rapid behavioral effects of corticosterone in rats. Neuroendocrinology (1996) 0.89
Cannabinoid receptor agonists modulate oligodendrocyte differentiation by activating PI3K/Akt and the mammalian target of rapamycin (mTOR) pathways. Br J Pharmacol (2011) 0.89
Cannabidiol protects oligodendrocyte progenitor cells from inflammation-induced apoptosis by attenuating endoplasmic reticulum stress. Cell Death Dis (2012) 0.89
Evaluation of fetal vocal cords to select candidates for successful fetoscopic treatment of congenital high airway obstruction syndrome: preliminary case series. Fetal Diagn Ther (2013) 0.88
Feasibility and accuracy of fetal echocardiography using four-dimensional spatiotemporal image correlation technology before 16 weeks' gestation. Ultrasound Obstet Gynecol (2009) 0.88
Anandamide suppresses nitric oxide and TNF-alpha responses to Theiler's virus or endotoxin in astrocytes. Neuroreport (1997) 0.87
Evidence for cyclooxygenase activation by nitric oxide in astrocytes. Glia (1995) 0.86
The use of a variable cut-off value of cervical length in women admitted for preterm labor before and after 32 weeks. Ultrasound Obstet Gynecol (2007) 0.85
Regulation of the phosphatase calcineurin by insulin-like growth factor I unveils a key role of astrocytes in Alzheimer's pathology. Mol Psychiatry (2011) 0.85
The effect of perinatal exposure to estrogens on the sexually dimorphic response to novelty. Physiol Behav (1994) 0.85
Abnormal first-trimester ductus venosus blood flow: a marker of cardiac defects in fetuses with normal karyotype and nuchal translucency. Ultrasound Obstet Gynecol (2010) 0.84
Interleukin-1-beta induces pituitary adrenocorticotropin secretion: evidence for glucocorticoid modulation. Neuroendocrinology (1992) 0.84
Adrenocortical response to acute and chronic ethanol administration in rats. Psychopharmacology (Berl) (1983) 0.83
Gestational age- and estimated fetal weight-adjusted reference ranges for myocardial tissue Doppler indices at 24-41 weeks' gestation. Ultrasound Obstet Gynecol (2011) 0.83
Intra- and interobserver repeatability of fetal cardiac examination using four-dimensional spatiotemporal image correlation in each trimester of pregnancy. Ultrasound Obstet Gynecol (2010) 0.83
Dexamethasone regulation of interleukin-1-receptors in the hippocampus of Theiler's virus-infected mice: effects on virus-mediated demyelination. Eur J Pharmacol (1999) 0.82
Reference ranges for Doppler parameters of the fetal aortic isthmus during the second half of pregnancy. Ultrasound Obstet Gynecol (2006) 0.82
Carbachol stimulates c-fos expression and proliferation in oligodendrocyte progenitors. Brain Res Mol Brain Res (1996) 0.82
Interleukin-2 induces corticotropin-releasing hormone release from superfused rat hypothalami: influence of glucocorticoids. Endocrinology (1992) 0.82
Does pre-eclampsia influence fetal cardiovascular function in early-onset intrauterine growth restriction? Ultrasound Obstet Gynecol (2009) 0.82
Serum antibodies to oxidized low-density lipoprotein in pregnant women with preeclampsia and chronic hypertension: lack of correlation with lipid peroxides. Hypertens Pregnancy (2001) 0.81
Increased cerebrospinal fluid cAMP levels in Alzheimer's disease. Brain Res (1999) 0.81
Glutamate-stimulated production of inositol phosphates is mediated by Ca2+ influx in oligodendrocyte progenitors. Eur J Pharmacol (1997) 0.80
Hypersensitivity to serotonin and its agonists in serotonin-hyperinnervated neostriatum after neonatal dopamine denervation. Eur J Pharmacol (1994) 0.80
Endotoxin administration induced differential neurochemical activation of the rat brain stem nuclei. Brain Res Bull (1996) 0.79
Corticosteroidogenesis modulation by beta-endorphin and dynorphin1-17 in isolated rat adrenocortical cells. Peptides (1986) 0.79
Decreased spontaneous motor activity and startle response in nitric oxide synthase inhibitor-treated rats. Eur J Pharmacol (1995) 0.79
Oligodendrocytes in brain and optic nerve express the beta3 subunit isoform of Na,K-ATPase. Glia (2000) 0.79
Effects of HPA hormones on adapted lymphocyte responsiveness to repeated stress. Brain Res Bull (1992) 0.78
Naltrindole administration during the preweanling period and manipulation affect adrenocortical reactivity in young rats. Brain Res Dev Brain Res (1999) 0.78
Mutually antagonistic effects of corticosterone and prolactin on rat lymphocyte proliferation. Neuroendocrinology (1992) 0.78
Feticide followed by mifepristone-misoprostol regimen for midtrimester termination of pregnancy in two cases of complete placenta previa. Fetal Diagn Ther (2010) 0.78
Beta-endorphin administration interferes with the acquisition and initial maintenance of ethanol preference in the rat. Physiol Behav (1989) 0.78
Involvement of kappa type opioids on ethanol drinking. Life Sci (1988) 0.78
Anti-myelin antibodies play an important role in the susceptibility to develop proteolipid protein-induced experimental autoimmune encephalomyelitis. Clin Exp Immunol (2014) 0.78
Doppler assessment of fetal aortic isthmus blood flow in two different sonographic planes during the second half of gestation. Ultrasound Obstet Gynecol (2005) 0.78
Inhibin A serum levels in proteinuric and nonproteinuric pregnancy-induced hypertension: evidence for placental involvement in gestational hypertension? Hypertens Pregnancy (2000) 0.78
Evidence for a role of nitric oxide in the corticotropin-releasing factor release induced by interleukin-1 beta. Eur J Pharmacol (1995) 0.77
Decompression through tracheobronchial endoscopy of bronchial atresia presenting as massive pulmonary tumor: a new indication for fetoscopic surgery. Fetal Diagn Ther (2012) 0.77
Distribution of indoleamines and [3H]paroxetine binding in rat brain regions following acute or perinatal delta 9-tetrahydrocannabinol treatments. Neurochem Res (1993) 0.77
[Cannabinoid system and neuroinflammation:therapeutic perspectives in multiple sclerosis]. Rev Neurol (2006) 0.77
Survival of AIDS according to injecting drug use among Puerto Rican AIDS patients. Cell Mol Biol (Noisy-le-grand) (2001) 0.77
Mobilization of progenitors in the subventricular zone to undergo oligodendrogenesis in the Theiler's virus model of multiple sclerosis: implications for remyelination at lesions sites. Exp Neurol (2013) 0.77
Effects of the kappa opioid receptor antagonist MR-2266-BS on the acquisition of ethanol preference. Life Sci (1990) 0.77
Effect of ethanol on corticosterone production by dispersed adrenal cells of the rat. Life Sci (1984) 0.77
Corticosteroid regulation of IL-1 receptors in the mouse hippocampus: effects of glucocorticoid treatment, stress, and adrenalectomy. Neuroendocrinology (1994) 0.77
Effects of cannabinoids on the immune system and central nervous system: therapeutic implications. BioDrugs (1999) 0.77
Effects of chronic lithium treatments on central dopaminergic receptor systems: G proteins as possible targets. Neurochem Int (1994) 0.77
N-Acetyl-cysteine inhibition of encephalomyelitis Theiler's virus-induced nitric oxide and tumour necrosis factor-alpha production by murine astrocyte cultures. Biofactors (1999) 0.76
Serum and placental lipid peroxides in chronic hypertension during pregnancy with and without superimposed preeclampsia. Hypertens Pregnancy (1999) 0.76
Glucocorticoids modulate rat hypothalamic corticotrophin-releasing factor release induced by interleukin-1. J Neurosci Res (1989) 0.76
[Early treatment of secondary hyperparathyroidism in moderate renal insufficiency: low-phosphorus diet versus calcium carbonate]. Nefrologia (2003) 0.76
Specific [3H]raclopride binding to neostriatal dopamine D2 receptors: role of disulfide and sulfhydryl groups. Neurochem Res (1992) 0.76
Evidence for nitric oxide-mediated rapid locomotor effects of corticosterone in a novel environment. Ann N Y Acad Sci (1994) 0.76
Prolonged ethanol consumption influences shuttle box and passive avoidance performance in rats. Physiol Behav (1985) 0.76
Regional and temporal modulation of brain glycoprotein synthesis by corticosterone. Neuroreport (1996) 0.76
Adrenal hormones and brain catecholamines responses to morning and afternoon immobilization stress in rats. Physiol Behav (1981) 0.76
Brain catecholamines during ethanol administration, effect of naloxone on brain dopamine and norepinephrine responses to withdrawal from ethanol. Pharmacol Res Commun (1985) 0.75
The Met-enkephalin analog D-Ala2-Met-enkephalinamide decreases the adrenocortical response to ACTH in dispersed rat adrenal cells. Peptides (1985) 0.75
Enkephalins interfere with early phases of voluntary ethanol drinking. Peptides (1990) 0.75
[Toxoplasma pericarditis and myocarditis]. Rev Chil Pediatr (1980) 0.75
[Colonization and infection in leukemic patients. Analysis of 195 surveillance cultures]. Medicina (B Aires) (1986) 0.75
[Poisoning by paralysing mollusk venom (red tide)]. Medicina (B Aires) (1986) 0.75
[Pacemaker implants in children]. Rev Chil Pediatr (1993) 0.75
[Thoracic tumors in children]. Rev Chil Pediatr (1978) 0.75
[Post-transfusional hepatitis. Preliminary study]. Sangre (Barc) (1991) 0.75
[Use of dental nurses to improve the curriculum of a dental school]. Bol Oficina Sanit Panam (1970) 0.75
[Treatment of aortic coarctation in children by plasty with the subclavian artery]. Rev Chil Pediatr (1987) 0.75
[Microbiological study of vaginitis and cervicitis]. Rev Chil Obstet Ginecol (1987) 0.75
[Epidemiology of von Willebrand's disease in the state of Zulia, Venezuela]. Invest Clin (1991) 0.75
[Acute leukemia in Venezuela. Study of the frequency of subtypes of acute leukemia by the FAB classification in the State of Zulia]. Sangre (Barc) (1984) 0.75
[Utilizing dental nurse type auxiliary personnel as a means for carrying out educational courses in a School of Dentistry]. Temas Odontol (1971) 0.75
Prothrombin Perija: a new congenital dysprothrombinemia in an Indian family. Thromb Res (1986) 0.75
[Malformations of the thoracic wall in children]. Rev Chil Pediatr (1983) 0.75
CB1 receptor antagonism/inverse agonism increases motor system excitability in humans. Eur Neuropsychopharmacol (2011) 0.75
[Resumés of technics for prevention of dental caries based on fluoride]. Temas Odontol (1969) 0.75